People | March 28, 2026
Shreehas Tambe appointed CEO & Managing Director of Biocon
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
This transaction fundamentally strengthens Scinai's CDMO platform
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
The proceeds from the ?IP will be primarily utilized to meet the cash consideration payable to Mylan Inc. (Viatris) for buying out its shareholding in Biocon Biologics Limited
The new assets expand Biocon Biologics’ already robust oncology portfolio, which now includes 17 cancer therapies
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
Subscribe To Our Newsletter & Stay Updated
